Literature DB >> 1319669

Neurosurgical experience with tumours of the pineal region at Clinica Puerta de Hierro.

J Vaquero1, J Ramiro, R Martínez, G Bravo.   

Abstract

The clinicopathological experience with 50 cases of pineal region tumours at Clinica Puerta de Hierro is presented. In this series, 88% of the patients were evaluated by CT-scan. Pineal region tumours make up approximately 0.7% of the intracranial expansive processes in the Spanish population. The largest group of lesions appearing in this localization is that of the germinomas (38%), followed by nontumoural lesions (20%) and tumours generally considered to be of the vicinity, such as meningiomas, gliomas and metastases (18%), tumours of the pineal parenchyma (14%), and non-germinoma germinal tumours (10%). In our series, in addition to an intracranial hypertension syndrome, an ophthalmological and, to a minor degree, an endocrinological syndrome predominate in germ-cell tumours, with a cerebellar syndrome appearing in gliomas of the pineal region. All the patients in the series diagnosed as having a germinoma and treated by irradiation are alive, and free of disease, after follow-up ranging from 2 to 20 years (mean: 8 years). The experience obtained with the present series supports the opinion that, in radiosensitive tumours, surgical resection adds no therapeutic benefit to treatment with radiotherapy alone. We suggest that when dealing with a tumour of the pineal region, CT-scan and clinical assessment now permit an initial selection of patients susceptible to surgery as a first therapeutic option, indicating those patients who, because they are considered to have either a "probable germinoma" or a "tumour of uncertain diagnosis", should undergo stereotaxic biopsy or trial radiotherapy and, only when this has proved a failure, should be subjected to open surgery.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319669     DOI: 10.1007/bf01541249

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  38 in total

1.  Results of irradiation of tumors in the region of the pineal body.

Authors:  N J Smith; A M El-Mahdi; W C Constable
Journal:  Acta Radiol Ther Phys Biol       Date:  1976-02

2.  Treatments and prognoses of pineal tumors--experience of 110 cases.

Authors:  K Ueki; R Tanaka
Journal:  Neurol Med Chir (Tokyo)       Date:  1980-01       Impact factor: 1.742

3.  Radiation therapy of pineal tumors.

Authors:  Y Onoyama; K Ono; T Nakajima; M Hiraoka; M Abe
Journal:  Radiology       Date:  1979-03       Impact factor: 11.105

4.  Immunohistochemical study of placental alkaline phosphatase in primary intracranial germ-cell tumors.

Authors:  J Shinoda; Y Miwa; N Sakai; H Yamada; H Shima; K Kato; M Takahashi; K Shimokawa
Journal:  J Neurosurg       Date:  1985-11       Impact factor: 5.115

5.  Cavernous angiomas of the pineal region. Report of two cases.

Authors:  J Vaquero; R Carrillo; J Cabezudo; G Leunda; F Villoria; G Bravo
Journal:  J Neurosurg       Date:  1980-12       Impact factor: 5.115

6.  Computed tomography of pineal, parapineal, and histologically related tumors.

Authors:  R A Zimmerman; L T Bilaniuk; J H Wood; D A Bruce; L Schut
Journal:  Radiology       Date:  1980-12       Impact factor: 11.105

7.  Surgical approach to pineal tumours.

Authors:  F Pluchino; G Broggi; M Fornari; A Franzini; C L Solero; A Allegranza
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

8.  Primary pineal endodermal sinus tumor with elevated serum and CSF alphafetoprotein levels. Case report.

Authors:  N Arita; S Bitoh; Y Ushio; T Hayakawa; H Hasegawa; M Fujiwara; K Ozaki; L Par-khen; T Mori
Journal:  J Neurosurg       Date:  1980-08       Impact factor: 5.115

9.  Alphafetoprotein and human chorionic gonadotropin determination in cerebrospinal fluid. An aid to the diagnosis and management of intracranial germ-cell tumors.

Authors:  J C Allen; J Nisselbaum; F Epstein; G Rosen; M K Schwartz
Journal:  J Neurosurg       Date:  1979-09       Impact factor: 5.115

10.  CT of pineal region tumors.

Authors:  S R Ganti; S K Hilal; B M Stein; A J Silver; M Mawad; P Sane
Journal:  AJR Am J Roentgenol       Date:  1986-03       Impact factor: 3.959

View more
  8 in total

Review 1.  Surgical approaches to pineal region tumors.

Authors:  K M Little; A H Friedman; T Fukushima
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

2.  Differences still exist in the approach to the diagnosis and management of pineal lesions.

Authors:  S Senan
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

3.  Intracranial germ-cell tumours--treatment results and residuals.

Authors:  C Haupt; U Ancker; M Muller; H D Herrmann; F J Schulte
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

4.  Gliomas of the pineal region.

Authors:  Salima Magrini; Alberto Feletti; Elisabetta Marton; Pierluigi Longatti
Journal:  J Neurooncol       Date:  2013-07-03       Impact factor: 4.130

Review 5.  Surgical strategies for treating patients with pineal region tumors.

Authors:  Jeffrey N Bruce; Alfred T Ogden
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

6.  Upfront Stereotactic Radiosurgery for Pineal Parenchymal Tumors in Adults.

Authors:  Jong Hoon Park; Jeong Hoon Kim; Do Hoon Kwon; Chang Jin Kim; Shin Kwang Khang; Young Hyun Cho
Journal:  J Korean Neurosurg Soc       Date:  2015-10-30

7.  Endoscopic options in management of posterior third ventricular tumors.

Authors:  S V Roopesh Kumar; Aaron Mohanty; Vani Santosh; Satyanarayana Satish; B Indira Devi; Shanti Shankar Praharaj; Sastry V R Kolluri
Journal:  Childs Nerv Syst       Date:  2007-05-31       Impact factor: 1.475

8.  Case Report: Metastatic Bronchopulmonary Carcinoid Tumor to the Pineal Region.

Authors:  Joshua A Cuoco; Michael W Kortz; Edwin McCray; Evin L Guilliams; Christopher M Busch; Cara M Rogers; Robert W Jarrett; Sandeep Mittal
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-31       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.